|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED
Nominal 
33.660 +9.860 (+41.429%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,147,840 | 157.292% | 1,706,678 | 706,678 | 125,932 | 12,792 |
| Cost of Sales | (348,522) | 137.529% | (524,775) | (179,794) | (34,414) | (4,645) |
| Gross Profit | 799,318 | 166.978% | 1,181,903 | 526,884 | 91,518 | 8,147 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 89,044 | -- | 12,728 | 2,645 | 3,667 | (23,362) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (39,929) | -- | (39,151) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 24,394 | -- | (598,364) | (1,041,375) | (844,463) | (247,275) | |
| Taxation | (30,338) | -- | 300,598 | 0 | 0 | (8) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (5,944) | -97.620% | (297,766) | (1,041,375) | (844,463) | (247,283) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (7,889) | -38.222% | (42,014) | (73,024) | (84,608) | (32,887) |
| Depreciation & Amortisation | 85,485 | 9.983% | 156,524 | 133,618 | 76,966 | 42,772 |
| Directors' Emoluments | -- | -- | 80,764 | 72,534 | 42,398 | 68,728 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -2.000 | -97.403% | -89.000 | -324.000 | -270.000 | -83.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.275) | (2.117) | (2.457) | (3.883) |
| NBV per share ($) | 14.779 | -- | 15.000 | 12.474 | 15.349 | 18.118 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -5,944 |
| %Change | -97.620% |
| EPS / (LPS) | RMB -0.020 |
| NBV Per Share (¥) | RMB 14.779 |